0001209191-14-065400.txt : 20141030 0001209191-14-065400.hdr.sgml : 20141030 20141030161926 ACCESSION NUMBER: 0001209191-14-065400 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141029 FILED AS OF DATE: 20141030 DATE AS OF CHANGE: 20141030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 141183477 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-10-29 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2014-10-29 4 M 0 4800 10.41 A 343695 D Common Stock 2014-10-29 4 M 0 1300 17.16 A 344995 D Common Stock 2014-10-29 4 M 0 4400 35.64 A 349395 D Common Stock 2014-10-29 4 S 0 3900 108.82 D 345495 D Common Stock 2014-10-29 4 S 0 6500 109.79 D 338995 D Common Stock 2014-10-29 4 S 0 100 110.47 D 338895 D Common Stock 13286 I 401(k) Common Stock 300000 I Common Stock held in trust Stock Option (right to buy) 10.41 2014-10-29 4 M 0 4800 0.00 D 2015-02-02 Common Stock 4800 62588 D Stock Option (right to buy) 17.16 2014-10-29 4 M 0 1300 0.00 D 2015-07-19 Common Stock 1300 48600 D Stock Option (right to buy) 35.64 2014-10-29 4 M 0 4400 0.00 D 2016-02-01 Common Stock 4400 586800 D Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1. Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $108.82 (range $108.43 to $109.38). Open market sales reported on this line occurred at a weighted average price of $109.79 (range $109.44 to $110.10). Common stock held in grantor retained annuity trusts. Fully vested. Kenneth L. Horton, Attorney-In-Fact 2014-10-30